uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
7.45
+0.86 (13.05%)
At close: Dec 6, 2024, 4:00 PM
7.40
-0.05 (-0.67%)
After-hours: Dec 6, 2024, 5:22 PM EST
uniQure Employees
uniQure had 480 employees as of December 31, 2023. The number of employees decreased by 21 or -4.19% compared to the previous year.
Employees
480
Change (1Y)
-21
Growth (1Y)
-4.19%
Revenue / Employee
$59,556
Profits / Employee
-$498,960
Market Cap
363.14M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AC Immune | 161 |
iTeos Therapeutics | 157 |
Nyxoah | 147 |
Sanara MedTech | 108 |
Rezolute | 51 |
Artiva Biotherapeutics | 43 |
Q32 Bio | 37 |
Immutep | 31 |
QURE News
- 15 days ago - uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy - GlobeNewsWire
- 4 weeks ago - uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress - GlobeNewsWire
- 7 weeks ago - uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS - GlobeNewsWire
- 2 months ago - uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease - GlobeNewsWire
- 4 months ago - uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease - GlobeNewsWire
- 4 months ago - uniQure: Pullback After Strong Interim Treatment Data Creates Buying Opportunity - Seeking Alpha
- 4 months ago - uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 4 months ago - uniQure Announces Closing of Sale of Manufacturing Facility to Genezen - GlobeNewsWire